Hlavatý J - Search Results

1

Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.

Hlavatý J, Hlubinová K, Bies J, Altaner C. Hlavatý J, et al. Neoplasma. 1999;46(6):329-34. Neoplasma. 1999. PMID: 10732860

2

Treatment of rat gliomas with recombinant retrovirus harboring Herpes simplex virus thymidine kinase suicide gene.

Hlavatý J, Hlubinová K, Altanerová V, Líska J, Altaner C. Hlavatý J, et al. Neoplasma. 1997;44(6):342-7. Neoplasma. 1997. PMID: 9605005

3

Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene.

Hlavatý J, Hlubinová K, Altaner C. Hlavatý J, et al. Neoplasma. 1999;46(5):267-76. Neoplasma. 1999. PMID: 10665841

4

Retrovirus vector containing wild type p53 gene and its effect on human glioma cells.

Hlavatý J, Tyukosova S, Bies J, Hlubinova K, Altaner C. Hlavatý J, et al. Neoplasma. 2000;47(4):204-11. Neoplasma. 2000. PMID: 11043823

5

Human glioma cells expressing herpes simplex virus thymidine kinase gene treated with acyclovir, ganciclovir and bromovinyldeoxyuridine. Evaluation of their activity in vitro and in nude mice.

Hlubinová K, Hlavatý J, Altaner C. Hlubinová K, et al. Among authors: hlavaty j. Neoplasma. 2001;48(5):398-406. Neoplasma. 2001. PMID: 11845986

6

The human homologue of the bovine leukemia virus receptor BLVRcp1 is the delta-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51.

Ban J, Hlavaty J, Orlik O, Splitter GA, Altaner C. Ban J, et al. Among authors: hlavaty j. Arch Virol. 1999;144(10):2013-22. doi: 10.1007/s007050050722. Arch Virol. 1999. PMID: 10550673

7

Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.

Orlik O, Ban J, Hlavaty J, Altaner C, Kettmann R, Portetelle D, Splitter GA. Orlik O, et al. Among authors: hlavaty j. J Virol. 1997 Apr;71(4):3263-7. doi: 10.1128/JVI.71.4.3263-3267.1997. J Virol. 1997. PMID: 9060692 Free PMC article.

8

Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.

Lötsch D, Steiner E, Holzmann K, Spiegl-Kreinecker S, Pirker C, Hlavaty J, Petznek H, Hegedus B, Garay T, Mohr T, Sommergruber W, Grusch M, Berger W. Lötsch D, et al. Among authors: hlavaty j. Oncotarget. 2013 Nov;4(11):1904-18. doi: 10.18632/oncotarget.1264. Oncotarget. 2013. PMID: 24243798 Free PMC article.

9

Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.

Hlavaty J, Stracke A, Klein D, Salmons B, Günzburg WH, Renner M. Hlavaty J, et al. J Virol. 2004 Feb;78(3):1384-92. doi: 10.1128/jvi.78.3.1384-1392.2004. J Virol. 2004. PMID: 14722293 Free PMC article.

10

Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma.

Hlavaty J, Jandl G, Liszt M, Petznek H, König-Schuster M, Sedlak J, Egerbacher M, Weissenberger J, Salmons B, Günzburg WH, Renner M. Hlavaty J, et al. J Neurooncol. 2011 Mar;102(1):59-69. doi: 10.1007/s11060-010-0295-5. Epub 2010 Jul 11. J Neurooncol. 2011. PMID: 20623247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters